52-Week Low Club (MAR 26, 2007)
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $374.15 +3.55%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +2.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +2.6%
Join SI Premium – FREE
From 247WallSt
Amgen (Nasdaq: AMGN) $57.14 (-1.5%)
As the FDA keeps talking up generic biotech drugs, Amgen is the first at risk. It actually closed up 3% from the $57.11 low so it avoided the lows intraday but put in a 52-week low close.
Angiotech (Nasdaq: ANPI) $5.62 (7.2%)
Here's what happens when your partner is in drug eluting stents and a competitor shows better results in a study.
Boston Scientific (NYSE: BSX) $14.22 (-6.5%)
Angiotech's dominant partner, when does this one stop?
Celebrate Express (Nasdaq: BDAY) $8.17 (-3.4%)
Not enough celebrations? Still has a $1.25 special dividend set for next month; didn't stay on 52-week lows but still acting very weak.
CV Therapeutics (Nasdaq: CVTX) $6.75 (-21%)
Deutsche Bank cut to Sell with a prediction of a 75% drop.
Jabil (NYSE: JBL) $22.11 (-0.7%)
Techs staged a late day recovery, but not for this EMS company that warned last week.
McClatchy (NYSE: MNI) $32.00 (-5.15%)
Newspapers....the good, the bad, and the fugly. This one didn't Stay under a new 52-week low but it put one in.
Tecumseh (Nasdaq: TECUA) $12.28 (-8.5%)
Now down more than 50% for the year. Another Michigan company in trouble.
Technical Olympic (NYSE: TOA) $4.37 (-6.2%)
Single family home maker didn't act well on poor housing numbers today and it's one of the weakest in the group.
Jon C. Ogg
For more market insight go to http://www.247wallst.com/
Amgen (Nasdaq: AMGN) $57.14 (-1.5%)
As the FDA keeps talking up generic biotech drugs, Amgen is the first at risk. It actually closed up 3% from the $57.11 low so it avoided the lows intraday but put in a 52-week low close.
Angiotech (Nasdaq: ANPI) $5.62 (7.2%)
Here's what happens when your partner is in drug eluting stents and a competitor shows better results in a study.
Boston Scientific (NYSE: BSX) $14.22 (-6.5%)
Angiotech's dominant partner, when does this one stop?
Celebrate Express (Nasdaq: BDAY) $8.17 (-3.4%)
Not enough celebrations? Still has a $1.25 special dividend set for next month; didn't stay on 52-week lows but still acting very weak.
CV Therapeutics (Nasdaq: CVTX) $6.75 (-21%)
Deutsche Bank cut to Sell with a prediction of a 75% drop.
Jabil (NYSE: JBL) $22.11 (-0.7%)
Techs staged a late day recovery, but not for this EMS company that warned last week.
McClatchy (NYSE: MNI) $32.00 (-5.15%)
Newspapers....the good, the bad, and the fugly. This one didn't Stay under a new 52-week low but it put one in.
Tecumseh (Nasdaq: TECUA) $12.28 (-8.5%)
Now down more than 50% for the year. Another Michigan company in trouble.
Technical Olympic (NYSE: TOA) $4.37 (-6.2%)
Single family home maker didn't act well on poor housing numbers today and it's one of the weakest in the group.
Jon C. Ogg
For more market insight go to http://www.247wallst.com/
You May Also Be Interested In
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
- Lindsay, Palantir rise premarket; Ouster, Bending Spoons fall
- OpenAI proposes handing Trump administration a 5% stake, FT reports
Create E-mail Alert Related Categories
ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
